FANGKE OEMCustom formulation and manufacturing project reviewSend project brief
Product directions
Unbranded packaging concept: Resurfacing feasibility
AI-generated white-label packaging concept. Final pack and appearance follow sample approval. View 4K upscaled image

Non-needle PHA, mandelic and controlled multi-acid resurfacing OEM

Custom development review · Resurfacing feasibility

A conventional surface-renewal serum avoids abrasive penetration mechanisms. Professional-strength products stay behind a feasibility and legal gate.

Discuss this product WhatsApp
MOQ & quotation
Confirmed for the selected formula, fill size, packaging and order plan.
Samples & production
Timing is confirmed after formula scope, packaging availability and required tests are reviewed.
Your brand
Original label and packaging design, with product wording reviewed for the destination market.

Formula, format & packaging options

Published reference values describe the cited ingredient or study. They are not test results for a FANGKE finished formula. Project options are selections to review in your development brief.

Non-needle PHA renewing serum

Gluconolactone/PHA water gel with humectants and a non-abrasive, surface-renewal application route.

Product format
Leave-on gel-serum or short-contact rinse-off gel, 30–50 mL
Packaging route
30–50 mL airless pump with acid-compatible spring/path
Non-needle PHA renewing serum Specifications
ParameterDevelopment detailBasis
Product formatLeave-on gel-serum or short-contact rinse-off gel, 30–50 mLProject option
Pack configuration30–50 mL airless pump with acid-compatible spring/pathProject option
Development routeProject screen 3–8% total PHA and pH 3.8–4.5 for consumer use after safety reviewProject option
Published PHA study benchmark10% gluconolactone peel in the cited studyPublished reference[1]

Checks for the selected formula

  • Measure free-acid/pH profile, irritation and cumulative-use tolerance for the exact instructions.
  • Run pack corrosion, pH drift, viscosity, preservative efficacy and sun-warning artwork review.

Destination-market notes

Position as gentle surface renewal only after tolerance testing. Avoid dermal-delivery, structural-change or acne-treatment language.

Mandelic acid + PHA gentle resurfacing serum

Mandelic Acid and Gluconolactone gel-serum with humectants and a buffered acid-compatible rheology system.

Product format
Leave-on or short-contact serum, 30–50 mL
Packaging route
Opaque 30–50 mL airless pump or controlled-drop bottle
Mandelic acid + PHA gentle resurfacing serum Specifications
ParameterDevelopment detailBasis
Product formatLeave-on or short-contact serum, 30–50 mLProject option
Pack configurationOpaque 30–50 mL airless pump or controlled-drop bottleProject option
Development routeConsumer route screened at 5–10% total hydroxy acids and final pH at or above 3.5, subject to market/safety reviewProject option
U.S. consumer AHA context10% or less AHA and final pH 3.5 or greater in the cited FDA/CIR contextPublished reference[2]

Checks for the selected formula

  • Quantify total/free acid, pH, buffer capacity and irritation across the intended use frequency.
  • Complete compatibility with pump components plus accelerated/real-time color, odor and viscosity stability.

Destination-market notes

Claims stay cosmetic and appearance-focused. U.S. acne or skin-lightening treatment language can create a drug route and is excluded from the standard page.

Professional multi-acid peel feasibility

AHA/PHA and optional BHA professional-use concept whose acids, neutralization and exposure time are selected only with toxicology and local legal review.

Product format
Professional short-contact liquid or gel, 15–50 mL
Packaging route
Tamper-evident acid-compatible bottle; neutralizer/directions assessed as a system
Professional multi-acid peel feasibility Specifications
ParameterDevelopment detailBasis
Product formatProfessional short-contact liquid or gel, 15–50 mLProject option
Pack configurationTamper-evident acid-compatible bottle; neutralizer/directions assessed as a systemProject option
Development routeNo public concentration promise; formula held behind professional-use, toxicology and jurisdiction gatesProject option
FDA consumer-use boundaryFDA's page reports a CIR conclusion only for consumer AHA products at 10% or less and finished pH 3.5 or above; it does not establish this professional concept's concentration, pH or use protocolPublished reference[2]

Checks for the selected formula

  • Obtain toxicologist sign-off on acid identity, free acid, pH, contact time, neutralization and misuse scenarios.
  • Validate professional instructions, training, packaging, neutralization endpoint and adverse-event process before any market trial.

Destination-market notes

Feasibility only. The cited salon context is not a formula authorization. Therapeutic claims, home use and export each require separate legal and safety decisions.

Project questions

Is the professional peel ready for retail or home use?

No. It is a feasibility direction. Formula strength, pH, instructions, professional restriction, classification and safety must be decided for one destination market before a sample or claim is approved.

Do source-reference values describe a ready Fangke formula?

No. They are traceable supplier, regulatory or research benchmarks. Formula ownership, raw-material grade, dosage, pilot feasibility, MOQ, lead time, claims and destination-market status are confirmed only for the individual project.

Which tests are included before commercialization?

The program is set after the formula, pack, intended use and market are known. Typical work includes specifications, stability, pack compatibility, microbiological quality or preservative efficacy and safety review. SPF, brightening, wrinkle or other performance claims need dedicated substantiation.

Technical references & source scope

These references support ingredient selection, formulation questions and market review. A quoted study, supplier test or regulatory limit does not establish finished-product efficacy or approval.

  1. Evaluation of the effects of 10% and 30% gluconolactone chemical peel on sebum, pH, and TEWL PubMed / Journal of Cosmetic Dermatology

    A 16-subject split-face study compared 10% and 30% gluconolactone solutions in three procedures. Those study concentrations are not universal safe or recommended levels and do not substantiate a different finished product.

  2. Alpha Hydroxy Acids U.S. Food and Drug Administration

    FDA reports the CIR consumer-use conclusion of AHA at 10% or less and final pH 3.5 or above, together with sun-sensitivity labeling context; professional products and therapeutic claims require separate review. These are not Fangke formula recommendations.

Content reviewed:

Send a product brief

Include your destination country, quantity, preferred option, fill size and packaging. We will review the formula route and quotation inputs.

Send project brief WhatsApp

Related development options

Unbranded packaging concept: Barrier hydrationBarrier hydration serum, cream and mist OEM Unbranded packaging concept: Peptide feasibilityCopper Tripeptide-1 serum and dual-chamber OEM feasibility Unbranded packaging concept: Healthy-aging serumsEctoin peptide, niacinamide barrier and bakuchiol serum OEM